An Open-label Study to Identify Molecular Markers of Steroid Resistance (MERK2)
This study is currently recruiting participants.
Verified January 2014 by Massachusetts General Hospital
Massachusetts General Hospital
Merck Sharp & Dohme Corp.
Massachusetts Eye and Ear Infirmary
Information provided by (Responsible Party):
Daniel Hamilos MD, Massachusetts General Hospital
First received: May 30, 2012
Last updated: January 17, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||July 2015|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|